Diagnostic Approach to Hyperglycemia and Hyperkalemia

Primary Concerns Requiring Workup

The American Diabetes Association recommends obtaining a hemoglobin A1C test immediately to assess chronic glycemic control and confirm or exclude diabetes mellitus, with A1C ≥6.5% confirming diabetes diagnosis, A1C 5.7-6.4% indicating prediabetes requiring intervention, and the test should be performed using an NGSP-certified method standardized to the DCCT assay 1, 2
Consider a formal 75-gram oral glucose tolerance test (OGTT) if A1C results are borderline or discordant with fasting glucose levels, with the OGTT considered the gold standard for diabetes diagnosis in certain populations, and a 2-hour plasma glucose ≥200 mg/dL confirming diabetes 1, 2, 3, 4, 5

The National Kidney Foundation recommends repeat potassium measurement with proper collection technique to exclude pseudohyperkalemia (hemolysis, prolonged tourniquet time, fist clenching) 3
If confirmed elevated, obtain serum aldosterone and plasma renin activity to evaluate for hypoaldosteronism, morning cortisol level to exclude adrenal insufficiency, and review all medications for potassium-sparing effects or drugs that impair potassium excretion 1, 3

The American Journal of Kidney Diseases recommends obtaining a urine albumin-to-creatinine ratio (UACR) to screen for diabetic kidney disease, with screening occurring at diabetes diagnosis for type 2 diabetes, and microalbuminuria (30-300 mg/g) indicating early diabetic kidney disease and cardiovascular risk 3, 4

The American Heart Association recommends obtaining a fasting lipid panel if not done recently, as patients with diabetes have elevated cardiovascular risk equivalent to those with prior myocardial infarction, and LDL cholesterol ≥100 mg/dL warrants consideration of statin therapy 6

Do not rely solely on fasting glucose for diabetes diagnosis when values are in the 100-125 mg/dL range, as this may miss cases that would be detected by A1C or OGTT, according to the American Diabetes Association 1, 3, 4
Do not delay urine albumin screening if diabetes is confirmed, as early detection and treatment of diabetic kidney disease significantly impacts long-term outcomes, as recommended by the National Kidney Foundation 3, 4